GSK2857916

Another myeloma drug with same target as CAR-Ts shows successful Phase II results

Without providing details, GlaxoSmithKline said its trial of BCMA-targeting belantamab mafodotin was positive. The company plans to submit for regulatory approvals later this year - potentially ahead of bluebird and Celgene's expected filing next year for the CAR-T bb2121.

By Alaric DeArment

BioPharma

GlaxoSmithKline steps into the myeloma game at European hematology conference

On Saturday, the company will present a poster of Phase I trial data for belantamab mafodotin, which targets the same antigen, BCMA, as Amgen bispecific antibody AMG 420 and multiple CAR-T cell therapies in development.

By Alaric DeArment

The Top Surgical Instruments Needed for Extractions

Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.

By ProdentUSA

The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond

Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.

By Fondren Orthopedic Group

How to Optimize Your Phlebotomy Setup for Efficient Patient Care

The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.

By CAPSA